Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 1
Submit an article Journal homepage
311
Views
11
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea

Genevieve DouglasDepartment of Clinical Haematology, Austin Hospital, University of Melbourne, Heidelberg, VIC, Australia; Correspondence[email protected]
,
Claire HarrisonDepartment of Haematology, Guys and St Thomas’ NHS Foundation Trust, London, UK;
,
Cecily ForsythWyong Hospital, Hamlyn Terrace, NSW, Australia;
,
Michael BennettDepartment of Haematology, Guys and St Thomas’ NHS Foundation Trust, London, UK;
,
William StevensonRoyal North Shore, Sydney, NSW, Australia;
,
John HounsellWarrnambool Base Hospital, Warrnambool, VIC, Australia;
,
Sumita RatnasingamRoyal Melbourne Hospital, Parkville, VIC, Australia;
,
David RitchieRoyal Melbourne Hospital, Parkville, VIC, Australia;
,
David M. RossFlinders University and Medical Centre and SA Pathology, Adelaide, SA, Australia
&
Andrew GriggDepartment of Clinical Haematology, Austin Hospital, University of Melbourne, Heidelberg, VIC, Australia;
show all
Pages 89-95 | Received 13 Dec 2015, Accepted 01 May 2016, Published online: 25 Jul 2016

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Michal Bar-Natan & Ronald Hoffman. (2020) Developing strategies to reduce the duration of therapy for patients with myeloproliferative neoplasms. Expert Review of Hematology 13:11, pages 1253-1264.
Read now

Articles from other publishers (10)

Jan Philipp Bewersdorf, Joan How, Lucia Masarova, Prithviraj Bose, Naveen Pemmaraju, John Mascarenhas & Raajit K. Rampal. (2023) Moving toward disease modification in polycythemia vera. Blood 142:22, pages 1859-1870.
Crossref
Ayalew Tefferi & Tiziano Barbui. (2023) Polycythemia vera: 2024 update on diagnosis, risk‐stratification, and management. American Journal of Hematology 98:9, pages 1465-1487.
Crossref
Anna L. Godfrey, Anna C. Green & Claire N. Harrison. (2023) Essential thrombocythemia: challenges in clinical practice and future prospects. Blood 141:16, pages 1943-1953.
Crossref
VinayKumar Bhardwaj, Deepak Sharma, Shanta Negi & Tarika Sharma. (2023) An atypical oral presentation of polycythemia vera. Journal of Dentistry Defence Section 17:1, pages 53.
Crossref
Ayalew Tefferi, Jean‐Christophe Ianotto, Vikram Mathews, Jan Samuelsson, Natasha Szuber, Zhijian Xiao & Peter Hokland. (2022) Myeloproliferative neoplasms – a global view. British Journal of Haematology 198:6, pages 953-964.
Crossref
Yoko Edahiro. (2022) Treatment options and pregnancy management for patients with PV and ET. International Journal of Hematology 115:5, pages 659-671.
Crossref
Ayalew Tefferi, Alessandro M. Vannucchi & Tiziano Barbui. (2021) Polycythemia vera: historical oversights, diagnostic details, and therapeutic views. Leukemia 35:12, pages 3339-3351.
Crossref
Rossella Renso, Andrea Aroldi, Pietro Pioltelli, Carlo Gambacorti-Passerini & Elena Maria Elli. (2018) Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea. Blood Cancer Journal 8:6.
Crossref
Ayalew Tefferi, Alessandro M. Vannucchi & Tiziano Barbui. (2018) Polycythemia vera treatment algorithm 2018. Blood Cancer Journal 8:1.
Crossref
Ayalew Tefferi, Alessandro M. Vannucchi & Tiziano Barbui. (2018) Essential thrombocythemia treatment algorithm 2018. Blood Cancer Journal 8:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.